GREAT VALLEY ADVISOR GROUP, INC.

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1769897 WILMINGTON, DE

Position in REGN

as of Jun 30, 2026 · filed Aug 10, 2026 Compact

Position Value

$236,321

-$128,360 QoQ

Shares Held

379

-34.1% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#1,003

of 1,322 holders

Holding Since

Jun 2020

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GREAT VALLEY ADVISOR GROUP, INC. holds $5,771,539 across 13 Biotechnology names. REGN ranks #7 (4.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARGX	Argenx SE	2,947	$2,734,138
2	CELC	Celcuity Inc.	5,591	$584,930
3	INCY	Incyte Corp	5,040	$571,334
4	VRTX	Vertex Pharmaceuticals Inc / Ma	874	$434,142
5	SMMT	Summit Therapeutics Inc.	25,840	$376,488
6	JAZZ	Jazz Pharmaceuticals plc	1,080	$260,247
7	REGN	Regeneron Pharmaceuticals, Inc. This page	379	$236,321
8	BBIO	BridgeBio Pharma, Inc.	2,700	$201,096

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$236,321	379	-34.1%	Shares	Sole	2026-08-10
2025-03-31	$364,681	575	+20.5%	Shares	Sole	2025-05-08
2024-12-31	$339,781	477	+7.9%	Shares	Sole	2025-02-24
2024-09-30	$464,648	442	+5.0%	Shares	Sole	2024-11-12
2024-06-30	$442,483	421	-35.6%	Shares	Sole	2024-07-16
2024-03-31	$629,468	654	+0.3%	Shares	Sole	2024-05-06
2023-12-31	$572,645	652	-43.5%	Shares	Sole	2024-02-06
2023-09-30	$949,695	1,154	+23.3%	Shares	Sole	2023-11-07
2023-06-30	$672,553	936	+22.5%	Shares	Sole	2023-08-10
2023-03-31	$627,755	764	+40.7%	Shares	Sole	2023-05-03
2021-09-30	$328,612	543	+30.2%	Shares	Sole	2021-10-14
2020-09-30	$233,428	417	+14.9%	Shares	Sole	2020-10-21
2020-06-30	$226,384	363	—	Shares	Sole	2020-07-31
No filing history on record for this holder in this stock.